EGRESS RD Trademark

Trademark Overview


On Wednesday, December 20, 2023, a trademark application was filed for EGRESS RD with the United States Patent and Trademark Office. The USPTO has given the EGRESS RD trademark a serial number of 98324211. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, January 7, 2025. This trademark is owned by Esperovax, Inc.. The EGRESS RD trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines; Oral vaccines; Modified cells for medical or clinical use; yeast-based pharmaceuticals for prevention or treatment of infectious diseases; Oral vaccine preparations; Pharmaceutical products for the treatment of infectious diseases; Recombinant yeast-based pharmaceutical products for prevention or treatment of infectious diseases; Yeast-based oral vaccines; Pharmaceutical preparations, namely, a drug delivery system for oral administration of vaccines comprising yeast-based oral vaccines; Pharmaceutical products, namely, yeast-based oral vaccines; Biological and pharmaceutical preparations, namely, recombinant yeast for prevention or treatment of infectious diseases
egress rd

General Information


Serial Number98324211
Word MarkEGRESS RD
Filing DateWednesday, December 20, 2023
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, January 7, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 26, 2024

Trademark Statements


Goods and ServicesVaccines; Oral vaccines; Modified cells for medical or clinical use; yeast-based pharmaceuticals for prevention or treatment of infectious diseases; Oral vaccine preparations; Pharmaceutical products for the treatment of infectious diseases; Recombinant yeast-based pharmaceutical products for prevention or treatment of infectious diseases; Yeast-based oral vaccines; Pharmaceutical preparations, namely, a drug delivery system for oral administration of vaccines comprising yeast-based oral vaccines; Pharmaceutical products, namely, yeast-based oral vaccines; Biological and pharmaceutical preparations, namely, recombinant yeast for prevention or treatment of infectious diseases
NOT AVAILABLE"RD"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, December 20, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEsperovax, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPlymouth, MI 48170

Party NameEsperovax, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPlymouth, MI 48170

Trademark Events


Event DateEvent Description
Wednesday, December 20, 2023NEW APPLICATION ENTERED
Monday, April 1, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, July 22, 2024NON-FINAL ACTION WRITTEN
Monday, July 22, 2024NON-FINAL ACTION E-MAILED
Monday, July 22, 2024ASSIGNED TO EXAMINER
Monday, July 22, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, October 22, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, October 22, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 22, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, October 28, 2024EXAMINERS AMENDMENT -WRITTEN
Monday, October 28, 2024EXAMINER'S AMENDMENT ENTERED
Monday, October 28, 2024EXAMINERS AMENDMENT E-MAILED
Monday, October 28, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, October 29, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 20, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 26, 2024PUBLISHED FOR OPPOSITION
Tuesday, November 26, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 7, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT